Table 2.
Patient | Stage | Day 0, Frequency (Freshly isolated and sorted cells out of total B cells) | Number of sorted cells (Day 0) | Day 7, Frequency (Freshly isolated and sorted cells out of total B cells) | Number of sorted cells (Day 7) |
---|---|---|---|---|---|
1 | III | <1/31,000 | 3 | <1/237 | 7 |
2 | II | <1/9000 | 5 | 1/250 | 40 |
3 | Ib | 1/20,000 | 6 | 1/5000 | 7 |
4 | IIa | <1/26,000 | 8 | 1/4200 | 2 |
5 | IIb | 1/30,000 | 25 | 1/25,000 | 20 |
6 | IIIA | 1/33,000 | 2 | 1/3,000 | 2 |
B-cell clones from patients with melanoma recognizing cancer cell-associated antigens conjugated on fluorescent beads were studied: a) from freshly isolated circulating B cells, selected by recognition of antigens conjugated on beads and sorted immediately; or b) after ex vivo culture with IL-17+BAFF+CpG for 7 days, prior to selection by binding to antigen-conjugated beads and single cell sorting. These suggest that these data suggest that individual B cell clones are likely to expand in response to innate stimuli and that the frequency of antigen-reactive clone selection was increased following ex vivo culture with IL-17+BAFF+CpG.